EP Patent

EP3880663A1 — Solid state forms of daprodustat and process for preparation thereof

Assigned to Teva Pharmaceuticals International GmbH · Expires 2021-09-22 · 5y expired

What this patent protects

The present disclosure encompasses solid state forms of Daprodustat, particularly crystalline polymorphs of Daprodustat, processes for preparation thereof, and pharmaceutical compositions thereof.

USPTO Abstract

The present disclosure encompasses solid state forms of Daprodustat, particularly crystalline polymorphs of Daprodustat, processes for preparation thereof, and pharmaceutical compositions thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3880663A1
Jurisdiction
EP
Classification
—
Expires
2021-09-22
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceuticals International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.